1-5 of 5
L. Castagna
Close
Sort by
Journal Articles

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV).

Antonella Anastasia, MD, Monica Balzarotti, Massimo Magagnoli, MD, Michele Spina, MD, Rita Mazza, MD, L. Castagna, Andrea Nozza, Stefania Bramanti, md, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro
Journal: Blood
Blood (2009) 114 (22): 1213.
https://doi.org/10.1182/blood.V114.22.1213.1213
Published: 2009
Journal Articles

Reduced-Intensity Conditioning for Allograft (RICT) after Cytoreductive Autograft (ASCT) in Relapsed/Resistant Hodgkin’s Lymphoma (HL)

A. M. Carella, E. Todisco, L. Castagna, A. Santoro, G. Catania, S Nati, A Congiu, R Vimercati, E Rossi, M Spriano, R Varaldo
Journal: Blood
Blood (2008) 112 (11): 3294.
https://doi.org/10.1182/blood.V112.11.3294.3294
Published: 2008
Journal Articles

Infusions of HSV-TK Engineered Donor Lymphocytes Effectively Protect Patients Undergoing Haploidentical Stem Cells Trasplantation (HSCT) from Infectious Mortality.

M.T. Lupo Stanghellini, MD, C. Bonini, MD, E. Provasi, BSC, M. Bernardi, MD, J. Peccatori, MD, A. Bondanza, MD, Z. Magnani, PhD, S.K. Perna, MD, F. Crippa, MD, V. Valtolina, PhD, M. Salomoni, PhD, L. Turchetto, PhD, S. Toma, PhD, C. Traversari, PhD, S. Colombi, PhD, C. Gallo Stampino, MD, P. Bruzzi, MD, L. Castagna, MD, J. Apperley, MD, S. Slavin, MD, F. Ciceri, MD, Claudio Bordignon, MD
Journal: Blood
Blood (2007) 110 (11): 1056.
https://doi.org/10.1182/blood.V110.11.1056.1056
Published: 2007
Journal Articles

A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo.

B. Bruno, MD, M. Rotta, MD, F. Patriarca, MD, D. Mattei, MD, B. Allione, MD, F. Carnevale-Schianca, MD, A. Rambaldi, MD, M. Casini, MD, V. Montefusco, MD, M. Parma, MD, P. Bavaro, MD, F. Onida, MD, A. Busca, MD, L. Castagna, MD, M.P. Iori, MD, D. Maloney, MD, B. Sandmaier, MD, F. Benedetti, MD, N. Mordini, MD, L. Giaccone, MD, R. Sorasio, MD, F. Fiore, MD, A. Filippi, MD, A. Palumbo, MD, M. Aglietta, MD, A. Levis, MD, R. Foà, MD, P. Di Bartolomeo, MD, E. Pogliani, MD, G. Lambertenghi-Deliliers, MD, M. Falda, MD, M. Petrini, MD, P. Corradini, MD, R. Fanin, MD, U. Ricardi, MD, R. Storb, MD, I. Baldi, B.Sc, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 3026.
https://doi.org/10.1182/blood.V110.11.3026.3026
Published: 2007
Journal Articles

HSV-TK Engineered Donor Lymphocytes Add-Backs Reduce Late Mortality and Improve Survival of High Risk Acute Leukemia after Haplo-HSCT: Results of a Phase II Multicenter Trial.

F. Ciceri, MD, C. Bonini, MD, M.T. Lupo Stanghellini, MD, A. Bondanza, MD, Z. Magnani, PhD, S. Perna, MD, M. Bernardi, MD, J. Peccatori, MD, A. Pescarollo, MD, P. Servida, MD, F. Crippa, MD, L. Callegaro, RN, M. Salomoni, PhD, L. Turchetto, PhD, S. Toma, PhD, P. Bruzzi, MD, L. Castagna, MD, A. Santoro, MD, J. Apperley, MD, S. Slavin, MD, S. Colombi, PhD, C. Gallo Stampino, MD, M. Bregni, MD, C. Bordignon, MD
Journal: Blood
Blood (2005) 106 (11): 439.
https://doi.org/10.1182/blood.V106.11.439.439
Published: 2005